Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update - ScienceDirect
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
Frontiers | Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy - ScienceDirect
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Cells | Free Full-Text | Immunotherapy, Inflammation and Colorectal Cancer
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Immunotherapy in colorectal cancer: current achievements and future perspective
Key immunotherapy trials in metastatic colorectal cancer (CRC). | Download Table
Trial to evaluate combination of CAR-T and pembrolizumab for metastatic colorectal cancer
Patients with MSI-High Colorectal Cancer Sought for Immunotherapy Trial – Consult QD
Frontiers | Colorectal cancer vaccines: The current scenario and future prospects
View of The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation | Annals of Gastroenterology
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
Immunotherapy trials in metastatic colorectal cancer | Download Table
